(Q39716120)

14 September 2017

The immortalizing and transforming ability of two common human papillomavirus 16 E6 variants with different prevalences in cervical cancer (English)

1 reference

14 September 2017

human papillomavirus 16

1 reference

inferred from title

cervix uterine cancer

1 reference

inferred from title

author

Stanislav N. Naryzhny

3

1 reference

14 September 2017

C Richard

1

1 reference

14 September 2017

C Lanner

2

1 reference

14 September 2017

L Sherman

4

1 reference

14 September 2017

H Lee

5

1 reference

14 September 2017

P F Lambert

6

1 reference

14 September 2017

I Zehbe

7

1 reference

14 September 2017

language of work or name

English

0 references

publication date

12 April 2010

1 reference

14 September 2017

1 reference

14 September 2017

29

1 reference

14 September 2017

23

1 reference

14 September 2017

3435-3445

1 reference

https://scigraph.springernature.com/pub.10.1038/onc.2010.93

14 September 2017

0 references

cites work

Normal growth and differentiation in a spontaneously immortalized near-diploid human keratinocyte cell line, NIKS.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.93

Identification of the protein encoded by the E6 transforming gene of bovine papillomavirus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.93

Activities of human papillomavirus 16 E6 natural variants in human keratinocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.93

The clinical importance of the nomenclature, evolution and taxonomy of human papillomaviruses

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.93

Genome variation of human papillomavirus types: phylogenetic and medical implications

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.93

Asian-American variants of human papillomavirus 16 and risk for cervical cancer: a case-control study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.93

Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.93

Ubiquitin-independent degradation of p53 mediated by high-risk human papillomavirus protein E6.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.93

Glyceraldehyde 3-phosphate dehydrogenase is a SET-binding protein and regulates cyclin B-cdk1 activity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.93

Natural history and epidemiology of HPV infection and cervical cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.93

Human papillomavirus type 16 E6 amino acid 83 variants enhance E6-mediated MAPK signaling and differentially regulate tumorigenesis by notch signaling and oncogenic Ras.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.93

Diversifying selection in human papillomavirus type 16 lineages based on complete genome analyses

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.93

HPV variants and HLA polymorphisms: the role of variability on the risk of cervical cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.93

Gene expression analysis of interferon kappa in laser capture microdissected cervical epithelium

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.93

Increased Risk for Cervical Disease Progression of French Women Infected with the Human Papillomavirus Type 16 E6-350G Variant

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.93

Creation of human tumour cells with defined genetic elements

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.93

31 March 2020

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.93

HPV16-E6 associated hTERT promoter acetylation is E6AP dependent, increased in later passage cells and enhanced by loss of p300.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.93

Selective loss of AKR1C1 and AKR1C2 in breast cancer and their potential effect on progesterone signaling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.93

Variants of the long control region and the E6 oncogene in European human papillomavirus type 16 isolates: implications for cervical disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.93

HPV-18 immortalization of human keratinocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.93

The mRNA expression of hTERT in human breast carcinomas correlates with VEGF expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.93

Telomerase activation by the E6 gene product of human papillomavirus type 16.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.93

Cellular life span and the Warburg effect

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.93

Human telomerase reverse transcriptase as a critical determinant of telomerase activity in normal and malignant endometrial tissues

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.93

Human papillomavirus 16 E6, L1, L2 and E2 gene variants in cervical lesion progression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.93

HPV16 E6 natural variants exhibit different activities in functional assays relevant to the carcinogenic potential of E6.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.93

Differential expression of keratins 10, 17, and 19 in normal cervical epithelium, cervical intraepithelial neoplasia, and cervical carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.93

FLICE/caspase-8 activation triggers anoikis induced by beta1-integrin blockade in human keratinocytes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.93

Effects of the human papilloma virus HPV-16 E7 oncoprotein on glycolysis and glutaminolysis: role of pyruvate kinase type M2 and the glycolytic-enzyme complex

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.93

Degradation of p53, not telomerase activation, by E6 is required for bypass of crisis and immortalization by human papillomavirus type 16 E6/E7.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.93

Characterization of proliferating cell nuclear antigen (PCNA) isoforms in normal and cancer cells: there is no cancer-associated form of PCNA.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.93

Structural and functional analysis of E6 oncoprotein: insights in the molecular pathways of human papillomavirus-mediated pathogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.93

Cancer. Puzzling patterns of predisposition

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.93

Steroid hormone transforming aldo-keto reductases and cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.93

The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.93

Assignment of the gene(s) involved in the expression of the proliferation-related Ki-67 antigen to human chromosome 10

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.93

Human papillomavirus type 16 DNA sequence.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.93

Binding of human papillomavirus type 16 E6 to E6AP is not required for activation of hTERT

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.93

hAda3 degradation by papillomavirus type 16 E6 correlates with abrogation of the p14ARF-p53 pathway and efficient immortalization of human mammary epithelial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.93

Human papillomavirus type 16 E6 and E7 oncogenes abrogate radiation-induced DNA damage responses in vivo through p53-dependent and p53-independent pathways

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.93

Telomerase activation in cervical keratinocytes containing stably replicating human papillomavirus type 16 episomes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.93

Telomerase components as a diagnostic tool in human oral lesions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.93

Relation between infection with a subtype of HPV16 and cervical neoplasia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.93

Understanding the Warburg effect: the metabolic requirements of cell proliferation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.93

Genomic variation of human papillomavirus type 16 and risk for high grade cervical intraepithelial neoplasia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.93

Human papillomavirus type 16 and 18 variants: race-related distribution and persistence

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.93

Risk for high-grade cervical intraepithelial neoplasia associated with variants of human papillomavirus types 16 and 18.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.93

Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.93

Risk of cervical cancer and geographical variations of human papillomavirus 16 E6 polymorphisms

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.93

Overriding of cyclin-dependent kinase inhibitors by high and low risk human papillomavirus types: evidence for an in vivo role in cervical lesions.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.93

Human papillomavirus 16 E6 polymorphisms in cervical lesions from different European populations and their correlation with human leukocyte antigen class II haplotypes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.93

Association between human papillomavirus 16 E6 variants and human leukocyte antigen class I polymorphism in cervical cancer of Swedish women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.93

Human papillomavirus 16 E6 variants differ in their dysregulation of human keratinocyte differentiation and apoptosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.93

Allosteric activation of acid alpha-glucosidase by the human papillomavirus E7 protein

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.93

Mutational analysis of human papillomavirus type 16 E6 demonstrates that p53 degradation is necessary for immortalization of mammary epithelial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.93

7 January 2021

inferred from DOI database lookup

Natural variants of the human papillomavirus type 16 E6 protein differ in their abilities to alter keratinocyte differentiation and to induce p53 degradation.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.93

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1038/ONC.2010.93

1 reference

Dimensions Publication ID

14 September 2017

0 references

1 reference